EXPERIENCE WITH COMBINATION VAGINAL AGENTS USED IN THE TREATMENT OF MIXED VAGINOSIS/VAGINITIS IN POSTMENOPAUSAL WOMEN
- Autores: Aivazova D.S.1
-
Afiliações:
- I.S. Turgenev Oryol State University
- Edição: Nº 5 (2016)
- Páginas: 134-137
- Seção: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247707
- ID: 247707
Citar
Texto integral
![Acesso aberto](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_open.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_unlock.png)
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Resumo
Objective. To evaluate the efficiency of a 2-step combination therapy cycle (broad-spectrum and local combined vaginal agents and probiotics) for mixed vaginosis/vaginitis in women during the menopausal transition and postmenopause in terms of patients’ subjective complaints. Subjects and methods. The prospective investigation included 28 women aged 53 to 65 years who had complaints of discomfort in the external genital area, such as itching, leucorrhoea, and unpleasant odour. All the patients underwent clinical, laboratory, overall and gynecological examinations. The femoflor test was used as a diagnostic one to study the vaginal microbial composition. The therapy of dysbiosis consisted of 2 steps: 1) the combined drug clindacin B prolong was used by the scheme: one intravaginal application of the drug overnight for 3 days (3 packages per treatment cycle) and 2) one intravaginal lactoginal suppository overnight for 14 days. Results. All the respondents reported improvement after the first step of treatment and no recurrences after its second step. Conclusion. Broad-spectrum combined agents demonstrate their efficacy just on the first day of short-term therapy cycles and the use of probiotics may prolong an interrecurrence interval.
Palavras-chave
Texto integral
![Acesso é fechado](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Sobre autores
Dianna Aivazova
I.S. Turgenev Oryol State University
Email: diana.aiwazowa@yandex.ru
Ph. D., associate professor Oryol, Russia
Bibliografia
- Соловьева А.В., Плаксина Н.Д., Сильвестрова Г.А. Вульвовагинальный кандидоз: как избежать рецидивов. Клиническая лекция. Радзинский В.Е., ред. М.: Редакция журнала StatusPraesens; 2013. 16с.
- Подзолкова Н.М., Кузнецова И.В., Коренная В.В. Гормональная терапия в пери- и постменопаузе. Руководство для врачей. М.: ГЭОТАР-Медиа; 2014: 35-56.
- Бебнева Т.Н., Добрецова Т.А. Смешанные вагинальные инфекции: новая идеология. Неспецифические вагинальные инфекции в практике акушера-гинеколога. Информационный бюллетень. Радзинский В.Е., Савичева А.М., ред. М.: Редакция журнала StatusPraesens; 2016. 24с.
- Радзинский В.Е., ред. Гинекология. Руководство по практическим занятиям по гинекологии. Учебное пособие. М.: ГЭОТАР-Медиа; 2013. 552с.
- Радзинский В.Е., Ордиянц И.М. Доказано в России. Исследование БИОС: сравнительная оценка различных схем лечения бактериального вагиноза и неспецифического вульвовагинита. StatusPraesens. 2013; 1: 52-5.
- Jahic M., Mulavdic M., Nurkic J., Jahic E., Nurkic M. Clinical characteristics of aerobic vaginitis and its association to vaginal candidiasis, trichomonas vaginitis and bacterial vaginosis. Med. Arch. 2013; 67(6): 428-30.
- Lynch M.E., Sobe J.D. Comparative in vitro activity of antimycotic agents against pathogenetic vaginal yeast isolates. J. Med. Vet. Mycol. 1994; 32(7): 267-74.
Arquivos suplementares
![](/img/style/loading.gif)